International Headache Society.- The international classification of headache disorders. 2nd edition. Cephalalgia, 2004, 24 (Suppl 1), 1-160.
Rasmussen BK.- Epidemiology of Headache. Cephalalgia, 2001, 21, 774-777.
Joutel A, Bousser MG, Biousse V, et al.- A gene for familial hemiplegic migraine maps to chromosome 19. Nat Gen, 1993, 5, 40-45.
Ophoff RA, Terwindt GM, Vergouwe MN, et al.- Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell, 1996, 87, 543-552.
Sandor PS, Ambrosini A, Agosti R, Schoenen J.- Genetics of migraine: possible links to neurophysiological abnormalities. Headache, 2002, 42, 365-377.
Pavlakis SG, Phillips PC, Di Mauro S, et al.- Mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes: a distinctive clinical syndrome. Ann Neurol, 1984, 16, 481-488.
Verin M, Rolland Y, Landgraf F, et al.- New phenotype of the cerebral autosomal dominant arteriopathy mapped to chromosome 19: migraine as the prominent clinical feature. J Neurol Neurosurg Psychiatry, 1995, 59, 579-585.
Cervera R, Piette JC, Font J, et al.- Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheumatol, 2002, 46, 1019-1027.
Ducros A, Denier C, Joutel A, et al.- The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med, 2001, 345, 17-24.
Thomsen LL, Ostergaard E, Olesen J, et al.- Evidence for a separate type of migraine with aura: Sporadic hemiplegic migraine. Neurology, 2003, 60, 595-601.
Tournier-Lasserve E, Joutel A, Melki J, et al.- Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy maps to chromosome 19p 12. Nat Gen, 1993, 3, 253-259.
Ducros A, Joutel A, Vahedi K, et al.- Mapping of a second locus for familial hemiplegic migraine to 1q21-23 and evidence of further heterogeneity. Ann Neurol, 1997, 42, 885-890.
De Fusco M, Marconi R, Silvestri L, et al.- Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Gen, 2003, 33, 192-196.
Marconi R, De Fusco M, Aridon P, et al.- Familial hemiplegic migraine type 2 is linked to 0.9Mb region on chromosome 1q23. Ann Neurol, 2003, 53, 376-381.
Moreno Davilla H.- Molecular and functional diversity of voltage-gated calcium channels. Ann NY Acad Sci, 1999, 868, 102-117.
Plomp JJ, Vergouwe MN, Van den Maagdenberg AM, et al.- Abnormal transmitter release at neuromuscular junctions of mice carrying the tottering alpha (1A) Ca2+ channel mutation. Brain, 2000, 123, 463-471.
Moseley AE, Lieske SP, Wetzel RK, et al.- Na, KATPase a2 isoform is expressed in neurons and its absence disrupts neuronal activity in newborn mice. J Biol Chem, 2003, 27, 5317-5324.
Mobasheri A, Avila J, Cozar-Castellano I, et al.- Na+, K+ - ATPase isoenzyme diversity; comparative biochemistry and physiological implications of novel functional interactions. Biosci Rep, 2000, 20, 51-91.
Ducros A, Tournier-Lasserve E, Bousser MG.- The genetics of migraine. Lancet Neurology, 2002, 1, 285-293.
Zhuchenko O, Bailey J, Bonnen J, et al.- Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Gen, 1997, 15, 62-69.
Vanmolkot KR, Kors EE, Hottenga JJ, et al.- Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol, 2003, 54, 360-6.
Casari G, Marconi R, de Fusco M, et al.- Haploinsifficiency of Na, K pump alpha2 subunit gene is responsible for familial hemiplegic migraine type 2. Cephalalgia, 2003, 23, 575.
D'Onofrio M, Ambrosini A Santorelli FM, et al.- A new mutation of the ATP1A2 gene in familial basilar migraine. Cephalalgia, 2004, 24, 149.
Hans M, Luvisetto S, Williams ME, et al.- Functional consequences of mutations in the human alpha1A calcium channel subunit linked to familial hemiplegic migraine. J Neurosci, 1999, 19, 1610-1619.
Kraus RL, Sinnegger MJ, Koschak A, et al.- Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics. J Biol Chem, 2000, 275, 9239-9243.
Tottene A, Fellin T, Pagnutti S, et al.- Familial hemiplegic migraine mutations increase Ca(2+) influx through single human Cav2.1 channels and decrease maximal Cav2.1 current density in neurons. Proc Natl Acad Sci USA, 2002, 99, 13284-13289.
Kunkler PE, Kraig RP.- Calcium waves precede electrophysiological changes of spreading depression in hippocampal organ cultures. J Neurosci, 1998, 18, 3416-3426.
Bolay H, Reuter U, Dunn AK, et al.- Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med, 2002, 8, 136-42.
Sappey-Marinier D, Vighetto A, Peyron R, et al.- Phosphorus and proton magnetic resonance spectroscopy in episodic ataxia type 2. Ann Neurol, 1999, 46, 256-259.
Pietrobon D.- Calcium channels and channelopathies of the central nervous system. Mol Neurobiol, 2002, 25, 31-50.
Weiller C, May A, Limmroth V, et al.- Brainstem activation in spontaneous human migraine attacks. Nat Med, 1995, 1, 658-660.
Van den Maagdenberg AM, Pietrobon D, Pizzorusso T, et al.- A Cacnal knockin mouse model with increased susceptibility to cortical spreading depression. Neuron, 2004, 41, 701-710.
Kraig RP, Ferreira-Filho CR, Nicholson C.- Alkaline and acid transients in cerebellar microenvirormement. J Neurophysiol, 1983, 49, 831-850.
May A, Ophoff RA, Terwindt GM, et al.- Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura. Hum Genet, 1995, 96, 604-608.
Nyholt DR, Lea RA, Goadsby PJ, et al.- Familial typical migraine: linkage to chromosome 19p13 and evidence for genetic heterogeneity. Neurology, 1998, 50, 1428-1432.
Terwindt GM, Ophoff RA, van Eijk R, et al.- Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology, 2001, 56, 1028-1032.
Jones KW, Ehm MG, Pericak-Vance MA, et al.- Migraine with aura susceptibility locus on chromosome 19p 13 is dinctinct from the familial hemiplegic migraine locus. Genomics, 2001, 78, 150-154.
Todt U, Heinze A, Zumbroich V, et al.- Systematic analysis of the familial hemiplegic migraine gene ATP1A2 in migraine with aura. Cephalalgia, 2003, 23, 662.
Knight YE, Bartsch T, Kaube H, Goadsby PJ.- P/Q-type calcium-channel blockade in the periaqueducal grey facilitates trigeminal nociception: a functional genetic link for migraine? J Neurosci, 2002, 22, RC213.
Asakura K, Kanemasa T, Mibnagawa K, et al. a-Eudesmol, a P/Q-type Ca2+ channel blocker, inhibits neurogenic vasodilatation and extravasation following eletrical stimulation of trigeminal ganglion. Br Res, 2000, 873, 94-101.
Sandor PS, Mascia A, Seidel L, et al.- Subclinical cerebellar impairment in the common types of migraine: a three-dimensional analysis of reaching movements. Ann Neurol, 2001, 49, 668-72.
Harno H, Hirvonen T, Kaunisto MA, et al.- Subclinical vestibulocerebellar dysfunction in migraine with and without aura. Neurology, 2003, 61, 1748-1752.
Neuhauser H, Leopold M, von Brevern M, et al.- The interrelations of migraine, vertigo, and migrainous vertigo. Neurology, 2001, 56, 436-441.
Neuhauser H, Lempert T. Vertigo and dizziness related to migraine: a diagnostic challenge. Cephalalgia, 2004, 24, 83-91.
Ulrich V, Gervil M, Kyvik KO, et al.- Evidence of a genetic factor in migraine with aura: a population-based Danish twin study. Ann Neurol, 1999, 45, 242-246.
Schoenen J, Ambrosini A, Sandor PS, et al.- Evoked potentials and transcranial magnetic stimulation in migraine: published data and viewpoint on their pathophysiologic significance. Clin Neurophysiol, 2003, 114, 955-972.
Sandor PS, Dydak U, Schoenen J, et al.- MR-spectroscopic imaging during visual stimulation in subgroups of migraine with aura. Cephalalgia, 2004, in press.
Ambrosini A, Garreffa G, Colonnese C, et al.- Cerebellar myo-inositol concentrations are increased in migraine with aura on 1H-NMR spectroscopy: a possible indication of altered Ca2+ homeostasis. Cephalalgia, 2003, 23, 574.
Herzog J, Wilke M, Jurkat-Rott K, et al.- Elevated myo-inositol is indicative for altered Ca2+ homeostasis in the cerebellum of familial hemiplegic migraine patients linked to CACNA1A on chromosome 19p13. J Neurol, 2001, 248, 445.
Westenbroek RE, Hoskins L, Catterall WA.- Localization of Ca2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals. J Neurosci, 1998, 18, 6319-6330.
Ambrosini A, de Noordhout AM, Alagona G, et al.- Impairment of neuromuscular transmission in a subgroup of migraine patients. Neurosci Lett, 1999, 276, 201-203.
Ambrosini A, Maertens de Noordhout A, Schoenen J.- Neuromuscular transmission in migraine: a single fiber EMG study in clinical subgroups. Neurology, 2001, 56, 1038-1043.
Ambrosini A, Pierelli F, Schoenen J.- Acetazolamide acts on neuromuscular transmission abnormalities found in some migraineurs. Cephalalgia, 2003, 23, 75-8.
Griggs RC, Moxley RT, Lafrance RA, et al.- Hereditary paroxysmal ataxia: response to acetazolamide. Neurology, 1978, 28, 1259-64.
Krivoi II.- Mechanisms of the non-neurotransmitter actions of acetylcholine in the neuromuscular apparatus. Neurosci Behav Physiol, 2002, 32, 149-156.
Estevez M, Gardner K.- Update on the genetics of migraine. Human Genetics, 2004, 114, 225-235.
Lea RA, Shepherd AG, Curtain RG, et al.- A typical migraine susceptibility region localizes to chromosome 1q31. Neurogenetics, 2002, 4, 17-22.
Gardner K, Barmada MM, Ptacek LJ, et al.- A new locus for hemiplegic migraine maps to chromosome 1q31. Cell, 1997, 87, 607-617.
McCarthy LC, Hosford DA, Riley JH, et al.- Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics, 2002, 78, 135-149.
Schroder H, Stovner LJ, Helde G et al.- Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ, 2001, 322, 19-22.
Tronvik E, Stovner LJ, Helde G, et al.- Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomised controlled trial. JAMA, 2003, 289, 65-69.
Valle N, Oterino A, Bravo Y, et al.- 5'-10' methylene-tetrahydrofolate reductase C677T polymorphism influences the risk for experiencing aura among migraineurs. Cephalalgia, 2003, 23, 577.
Schoenen J, Jacquy J, Lenaerts M.- Effectiveness of high-dose riboflavin in migaine prophylaxis. A randomized controlled trial. Neurology, 1998, 50, 466-470.
